Sanofi (SAN.PA)
Healthcare • Drug Manufacturers - General
StockParisFranceFR0000120578
88.07 EUR
+0.10% today Updated 13 Nov 2026 13:48
Kyvero is an independent information site. It is not affiliated with, endorsed by or sponsored by Sanofi, and has no access to any account you may have with it. The name and the logo belong to their owners.
Price history
Daily prices in EUR. Dividends, results and news are marked on the day they happened; click a day to see them.
Updated 13 Nov 2026 13:48. Information, not advice. Showing the last 12 months. Create a free account to see the whole history
Results
Next results
28 Jan 2027
in 76 days · 11:00 · estimate 1.72
Last results
3.55 vs 2.84 estimated
30 Oct 2026 · Beat +25.2%
Beat the estimate
9 of 12
3 missed · 0 in line · 5 beats in a row
Average surprise
+6.0%
reported against the estimate, last 12 quarters
Earnings per share: estimate and reported
Estimate Reported: beat Reported: miss In line
Quarterly results
| Date | EPS estimate | EPS reported | Surprise | Result |
|---|---|---|---|---|
| 28 Jan 2027 11:00 | 1.72 | — | — | Upcoming |
| 30 Oct 2026 02:00 | 2.84 | 3.55 | +25.2% | Beat |
| 30 Jul 2026 01:00 | 1.90 | 2.09 | +10.0% | Beat |
| 23 Apr 2026 01:00 | 1.80 | 1.88 | +4.5% | Beat |
| 29 Jan 2026 01:00 | 1.47 | 1.53 | +4.4% | Beat |
| 24 Oct 2025 10:00 | 2.70 | 2.91 | +7.9% | Beat |
| 30 Jul 2025 20:00 | 1.64 | 1.59 | -2.9% | Miss |
| 24 Apr 2025 01:00 | 1.67 | 1.79 | +7.1% | Beat |
| 30 Jan 2025 01:00 | 1.36 | 1.31 | -3.9% | Miss |
| 25 Oct 2024 04:00 | 2.50 | 2.86 | +14.5% | Beat |
| 25 Jul 2024 01:00 | 1.64 | 1.73 | +5.7% | Beat |
| 25 Apr 2024 01:00 | 1.71 | 1.78 | +4.3% | Beat |
| 01 Feb 2024 01:00 | 1.74 | 1.66 | -4.5% | Miss |
| 27 Oct 2023 12:00 | 2.61 | 2.55 | -2.4% | Miss |
| 28 Jul 2023 15:00 | 1.67 | 1.74 | +4.1% | Beat |
| 27 Apr 2023 01:00 | 2.00 | 2.16 | +7.9% | Beat |
| 03 Feb 2023 11:00 | 1.71 | 1.71 | 0.0% | In line |
| 28 Oct 2022 01:00 | 2.68 | 2.88 | +7.7% | Beat |
| 28 Jul 2022 02:00 | 1.65 | 1.73 | +4.7% | Beat |
| 28 Apr 2022 01:00 | 1.76 | 1.94 | +10.0% | Beat |
| 04 Feb 2022 01:00 | 1.36 | 1.38 | +1.7% | Beat |
| 28 Oct 2021 01:00 | 1.99 | 2.18 | +9.3% | Beat |
| 29 Jul 2021 01:00 | 1.32 | 1.38 | +4.2% | Beat |
| 28 Apr 2021 01:00 | 1.41 | 1.61 | +14.2% | Beat |
| 05 Feb 2021 01:00 | 1.17 | 1.22 | +4.5% | Beat |
| 29 Oct 2020 02:00 | 1.79 | 1.83 | +2.4% | Beat |
| 29 Jul 2020 01:00 | 1.21 | 1.28 | +5.5% | Beat |
| 24 Apr 2020 02:00 | 1.45 | 1.63 | +12.1% | Beat |
| 06 Feb 2020 01:00 | 1.28 | 1.34 | +4.9% | Beat |
| 31 Oct 2019 02:00 | 1.72 | 1.92 | +11.9% | Beat |
| 29 Jul 2019 01:00 | 1.24 | 1.31 | +5.5% | Beat |
| 26 Apr 2019 01:00 | 1.32 | 1.42 | +7.8% | Beat |
| 07 Feb 2019 01:00 | 1.12 | 1.10 | -1.4% | Miss |
| 31 Oct 2018 02:00 | 1.69 | 1.84 | +9.1% | Beat |
| 31 Jul 2018 01:00 | 1.22 | 1.25 | +2.4% | Beat |
| 27 Apr 2018 01:00 | 1.15 | 1.28 | +11.0% | Beat |
| 07 Feb 2018 01:00 | 1.14 | 1.06 | -6.8% | Miss |
| 02 Nov 2017 02:00 | 1.73 | 1.71 | -1.3% | Miss |
| 31 Jul 2017 01:00 | 1.31 | 1.35 | +3.3% | Beat |
| 28 Apr 2017 01:00 | 1.26 | 1.42 | +12.4% | Beat |
| 08 Feb 2017 01:00 | 1.22 | 1.25 | +2.1% | Beat |
| 28 Oct 2016 01:00 | 1.54 | 1.79 | +16.2% | Beat |
| 29 Jul 2016 01:00 | 1.30 | 1.31 | +0.9% | In line |
| 29 Apr 2016 01:00 | 1.29 | 1.34 | +4.1% | Beat |
| 09 Feb 2016 01:00 | 1.24 | 1.31 | +5.4% | Beat |
| 29 Oct 2015 02:00 | 1.59 | 1.61 | +1.2% | Beat |
| 30 Jul 2015 01:00 | 1.31 | 1.41 | +7.4% | Beat |
| 30 Apr 2015 01:00 | 1.20 | 1.32 | +9.9% | Beat |
| 05 Feb 2015 01:00 | 1.38 | 1.39 | +0.8% | In line |
| 28 Oct 2014 02:00 | 1.47 | 1.47 | -0.3% | In line |
Annual results · EUR
| Year | Revenue | Change | Net income | Net margin | EPS | EPS change | Free cash flow |
|---|---|---|---|---|---|---|---|
| 2025 | 46.7B | +5.5% | 7.8B | 16.7% | 6.40 | +39.4% | 7.2B |
| 2024 | 44.3B | +6.4% | 5.6B | 12.6% | 4.59 | +6.5% | 5.9B |
| 2023 | 41.6B | +2.6% | 5.4B | 13.0% | 4.31 | -19.7% | 7.4B |
| 2022 | 40.6B | — | 8.4B | 20.6% | 5.37 | — | 8.4B |
Dates and earnings per share from the company reports as collected by the data provider; the estimate is the analysts' average before the report. Information, not advice.
Prices by day, week and month
| Period | Opening price | High | Low | Closing price | Change | Volume | Dividend |
|---|---|---|---|---|---|---|---|
| 13 Nov 2026 | 88.12 | 88.37 | 87.77 | 88.07 | +0.10% | 533,895 | |
| 12 Nov 2026 | 87.50 | 88.48 | 87.50 | 87.98 | +1.58% | 2,939,322 | |
| 11 Nov 2026 | 85.70 | 86.61 | 85.56 | 86.61 | +0.77% | 2,855,036 | |
| 10 Nov 2026 | 86.10 | 86.25 | 85.42 | 85.95 | +0.22% | 3,213,951 | |
| 09 Nov 2026 | 84.40 | 86.10 | 84.39 | 85.76 | +2.41% | 2,881,635 | |
| 06 Nov 2026 | 83.04 | 83.80 | 81.74 | 83.74 | -0.93% | 3,228,987 | |
| 05 Nov 2026 | 84.50 | 85.37 | 83.82 | 84.53 | +0.51% | 3,387,033 | |
| 04 Nov 2026 | 81.88 | 84.10 | 81.05 | 84.10 | +3.85% | 3,466,706 | |
| 03 Nov 2026 | 81.80 | 82.01 | 80.86 | 80.98 | +0.43% | 2,794,848 | |
| 02 Nov 2026 | 79.12 | 80.63 | 78.70 | 80.63 | +1.12% | 2,836,923 | |
| 1,276 older periods: create a free account to see the whole history | |||||||
Prices in EUR, adjusted for splits but not for dividends. Weeks run Monday to Friday and months follow the calendar; the change compares each close with the previous period's. Dividends are those whose ex-dividend date falls in the period, per share. Information, not advice.
News
- Sanofi (SNY) Is Planning for a Patent Loss, Here’s Where Bulls Still See Opportunity (opens in a new tab) Insider Monkey · 10 Nov 2026 22:22
- NVAX Q3 2026 deep dive: Sanofi milestone and cost controls shape outlook (opens in a new tab) StockStory · 10 Nov 2026 13:01
- Novavax (NVAX) Looks Cheap After Sanofi Milestone And Stronger Q3 Results (opens in a new tab) Simply Wall St. · 07 Nov 2026 16:10
- Novavax Inc (NVAX) (Q3 2026) Earnings Call Highlights: Sanofi Milestone Lifts Revenue Outlook ... (opens in a new tab) GuruFocus.com · 06 Nov 2026 01:15
- Sanofi (ENXTPA:SAN) Could Be 16% Overvalued After Strong Q3 Results And Higher 2026 Guidance (opens in a new tab) Simply Wall St. · 05 Nov 2026 10:22
- Sanofi Stock And Why Earnings Guidance Raised Matters For Shareholders (opens in a new tab) Simply Wall St. · 05 Nov 2026 08:14
- Sanofi (ENXTPA:SAN) Stock Looks Discounted Despite Its 20% Monthly Run (opens in a new tab) Simply Wall St. · 05 Nov 2026 01:16
- Nurix, Sanofi Diverge — And One Breaks Out — On A Shocking Eczema Development (opens in a new tab) Investor's Business Daily · 04 Nov 2026 21:19
- NRIX Stock Clocks Worst Day Ever After Sanofi Discontinues Trial Of Licensed Drug: Wells Fargo Slashes Price Target (opens in a new tab) Stocktwits · 04 Nov 2026 21:14
- Sanofi (ENXTPA:SAN) Drops SAR448272 And Backs New Immunology Candidate (opens in a new tab) Simply Wall St. · 04 Nov 2026 19:14
- Sanofi stops development of Nurix-partnered immune drug (opens in a new tab) BioPharma Dive · 04 Nov 2026 17:18
- Nurix Therapeutics Shares Plunge 28.4% as Sanofi Terminates STAT6 Drug Development Programme (opens in a new tab) InvestorsHub · 04 Nov 2026 13:47
- Nurix Therapeutics stock tumbles on Sanofi program termination (opens in a new tab) Investing.com · 03 Nov 2026 21:54
- Recursion's Q3 Earnings Beat Estimates on Sanofi Milestone Revenues (opens in a new tab) Zacks · 03 Nov 2026 14:59
- Sanofi (SNY) Q3 2026 Earnings Call Transcript (opens in a new tab) Motley Fool · 02 Nov 2026 16:17
Headlines link to the original articles of the publishers shown; Kyvero does not write, check or endorse them. Only the most relevant news about each company is kept. Information, not advice.
Key data
- Previous close
- 87.98 EUR
- Market cap
- 105.4B
- Dividend yield
- 4.68%
- 5-year average yield
- 4.03%
- Payout ratio
- 119%
- Last dividend
- 4.1200 EUR · 05 May 2026
- Exchange
- Paris
- Country
- France
- Sector
- Healthcare
- Industry
- Drug Manufacturers - General
- Currency
- EUR
Dividends
| Ex-dividend date | Per share |
|---|---|
| 05 May 2026 | 4.1200 EUR |
| 12 May 2025 | 3.9200 EUR |
| 13 May 2024 | 3.7600 EUR |
| 30 May 2023 | 3.5600 EUR |
| 8 older dividends: create a free account to see them | |
Why this score
| Part of the score | Points | Why |
|---|---|---|
| Yield Dividends per year as a share of today's price. Very high yields count for less: they often signal trouble. | 19.5 / 25 |
|
| Dividend safety Can the company keep paying? The dividend against free cash flow and earnings, plus debt and interest cover. | 16.5 / 25 |
|
| Dividend growth How many years in a row the dividend has risen, and how fast. | 15.0 / 15 |
|
| Quality Return on equity, net margin and how stable the margins are. | 5.1 / 15 |
|
| Valuation Free cash flow yield and the P/E against its sector. | 9.3 / 10 |
|
| Analysts How far the analysts' average target is from today's price. | 3.1 / 5 |
|
- Score capped at 55: the dividend is not covered by free cash flow or earnings
- The dividend is above the earnings (payout 119%)
Income profile: it pays a dividend, so it is scored mainly on the dividend and how safe it is. Based on 95% of the figures (grade A). Warnings take 6 points off.
Warnings take points off and some cap the score. In your account the score also considers how the share fits your portfolio. How the score works
Figures
| Figure | Value | Reading | Sector median |
|---|---|---|---|
| P/E (trailing) | 25.43× | Weak | 30.56× |
| P/E (forward) | 9.34× | Good | 14.16× |
| Price / book | 1.45× | Good | 3.5× |
| Price / sales | 2.07× | Fair | 3.33× |
| EV / EBITDA | 8.11× | Good | 11.19× |
| Free cash flow yield | 7.8% | Good | 2.1% |
| Figure | Value | Reading | Sector median |
|---|---|---|---|
| Gross margin | 74.3% | Good | 54.9% |
| Operating margin | 22.3% | Good | 5.8% |
| Net margin | 8.2% | Fair | 1.2% |
| Return on equity | 5.7% | Weak | 4.4% |
| Return on assets | 5.5% | Fair | 2.7% |
| Figure | Value | Reading | Sector median |
|---|---|---|---|
| Revenue growth / year | 4.8% | Fair | 10.1% |
| EPS growth / year | 6% | Fair | 10.2% |
| Figure | Value | Reading | Sector median |
|---|---|---|---|
| Debt / equity | 0.27× | Good | 0.4× |
| Net debt / EBITDA | 0.94× | Good | 1.46× |
| Interest cover | 15.33× | Good | 2.17× |
| Current ratio | 1.12× | Fair | 2.64× |
| Figure | Value | Reading | Sector median |
|---|---|---|---|
| Payout of earnings | 119.1% | Weak | 0% |
| Payout of free cash flow | 57.7% | Fair | 28.7% |
| Payout of free cash flow (3 years) | 68.1% | Fair | — |
| Dividend growth / year | 10.5% | Good | 6.5% |
| Years of rising dividends | 18 | Good | 1.5 |
The reading follows general rules of thumb and each sector has its own norms: compare with the sector median when it is shown. Information, not advice.
Similar shares
Follow SAN.PA and get alerts
Create a free account to add it to your watchlist, set a price alert, see how it fits your portfolio and track your dividends.